SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-23-009252
Filing Date
2023-02-28
Accepted
2023-02-28 17:31:33
Documents
92
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K brhc10048995_10k.htm   iXBRL 10-K 2626496
2 EXHIBIT 31.1 brhc10048995_ex31-1.htm EX-31.1 11334
3 EXHIBIT 31.2 brhc10048995_ex31-2.htm EX-31.2 11099
4 EXHIBIT 32.1 brhc10048995_ex32-1.htm EX-32.1 5341
10 image00001.jpg GRAPHIC 37567
11 image00003.jpg GRAPHIC 28855
12 image00004.jpg GRAPHIC 24517
  Complete submission text file 0001140361-23-009252.txt   12039429

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rckt-20221231.xsd EX-101.SCH 83042
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rckt-20221231_cal.xml EX-101.CAL 96330
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rckt-20221231_def.xml EX-101.DEF 442705
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20221231_lab.xml EX-101.LAB 1194195
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20221231_pre.xml EX-101.PRE 660579
86 EXTRACTED XBRL INSTANCE DOCUMENT brhc10048995_10k_htm.xml XML 1839067
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36829 | Film No.: 23687661
SIC: 2834 Pharmaceutical Preparations